HOME Press Releases Electrophoresis Market worth 2.80 Billion USD by 2022



Electrophoresis Market worth 2.80 Billion USD by 2022


The report "Electrophoresis Market by Product (Gel Electrophoresis (Horizontal & Vertical) (Agarose & Polyacrylamide), Capillary Electrophoresis, Reagents, Geldoc, Imaging), Application (Diagnostic, Reasearch, Quality Control), End User - Global Forecast to 2022", The electrophoresis market is expected to reach USD 2.80 Billion by 2022 from an estimated USD 2.15 Billion in 2017, at a CAGR of 5.4%.

     Download PDF Brochure     Speak to Analyst     Inquiry Before Buying

Browse 204 market data tables and 46 figures spread through 244 pages and in-depth TOC on "Electrophoresis Market by Product (Gel Electrophoresis (Horizontal & Vertical) (Agarose & Polyacrylamide), Capillary Electrophoresis, Reagents, Geldoc, Imaging), Application (Diagnostic, Reasearch, Quality Control), End User - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/electrophoresis-market-434.html
Early buyers will receive 10% customization on reports.

Rising incidence of cancer, infectious diseases, and genetic disorders; growth in funding for research on genomic, proteomic, and electrophoresis techniques; growing number of industry-academia research collaborations; growing use of capillary electrophoresis with mass spectroscopy; and growth in the number of clinical, forensic, and research laboratories are the major factors driving the growth of the electrophoresis market during the forecast period.

“By product, the reagents segment accounted for the largest share of the market in 2016.”

On the basis of product, the reagent segment accounted for the largest share of the global electrophoresis market. This is primarily attributed to the increasing demand for 2D electrophoresis for protein separation for various applications such as biomarker discovery and protein mapping. Over the years, genomic and proteomic technologies have gained significant importance in fields of clinical diagnosis and drug discovery and development. These are some of the key factors driving the growth of the electrophoresis market, and in turn supporting the growth of the electrophoresis reagents market during the forecast period.

“By Application, the research segment held the largest market share in 2016.”

Based on application, the research segment accounted for the largest share of this market. Low cost and sensitive approach for DNA sequencing, the major role of electrophoresis in drug discovery, rising use of electrophoresis techniques as a result of growing importance of antibody research in the development of biotherapeutic are the major factors driving the use of electrophoresis, which has boosted the demand for research applications.

“North America dominated the market in 2016.”

North America accounted for the largest share of the electrophoresis market in 2016, followed by Europe and Asia-Pacific. The patent expiration of several blockbuster drugs of major pharmaceutical companies is, in turn, increasing investments for new drug discovery; this is a key market driver in North America. In addition, the growing focus of stakeholders on research projects involving proteins, associated biomolecules, and genes; stringent regulatory requirements regarding pharmaceutical manufacturing necessitating quality control and process validation processes; rising focus on the development of structure-based drug designs; and growing research activities in the fields of genomics and proteomics is attributed to the largest share of electrophoresis market in North America.

The prominent players in the global electrophoresis market are Bio-Rad Laboratories (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Merck Millipore (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Lonza Group Ltd. (Switzerland), Shimadzu Corporation (Japan), Harvard Bioscience, Inc. (U.S.), Sebia Group (U.K.), and C.B.S. Scientific Company, Inc. (U.S.).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports